Preveceutical Medical Stock Analysis
| PRVCF Stock | USD 0.02 0 5.98% |
PreveCeutical Medical has over 1.68 Million in debt which may indicate that it relies heavily on debt financing. PreveCeutical Medical's financial risk is the risk to PreveCeutical Medical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
PreveCeutical Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. PreveCeutical Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps PreveCeutical OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect PreveCeutical Medical's stakeholders.
For most companies, including PreveCeutical Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for PreveCeutical Medical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, PreveCeutical Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that PreveCeutical Medical's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which PreveCeutical Medical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of PreveCeutical Medical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, PreveCeutical Medical is said to be less leveraged. If creditors hold a majority of PreveCeutical Medical's assets, the OTC Stock is said to be highly leveraged.
PreveCeutical Medical is overvalued with Real Value of 0.0145 and Hype Value of 0.02. The main objective of PreveCeutical Medical otc analysis is to determine its intrinsic value, which is an estimate of what PreveCeutical Medical is worth, separate from its market price. There are two main types of PreveCeutical Medical's stock analysis: fundamental analysis and technical analysis.
The PreveCeutical Medical otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PreveCeutical Medical's ongoing operational relationships across important fundamental and technical indicators.
PreveCeutical |
PreveCeutical OTC Stock Analysis Notes
About 24.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. PreveCeutical Medical last dividend was issued on the 14th of July 2017. The entity had 5:1 split on the 23rd of May 2018. PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for PreveCeutical Medical is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about PreveCeutical Medical contact Stephen Deventer at 604 416 7777 or learn more at https://www.preveceutical.com.PreveCeutical Medical Investment Alerts
| PreveCeutical Medical is way too risky over 90 days horizon | |
| PreveCeutical Medical has some characteristics of a very speculative penny stock | |
| PreveCeutical Medical appears to be risky and price may revert if volatility continues | |
| PreveCeutical Medical has high likelihood to experience some financial distress in the next 2 years | |
| PreveCeutical Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 2.25 K. | |
| PreveCeutical Medical has accumulated about 2.64 K in cash with (426.39 K) of positive cash flow from operations. | |
| Roughly 24.0% of PreveCeutical Medical outstanding shares are owned by corporate insiders |
PreveCeutical Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PreveCeutical Medical's market, we take the total number of its shares issued and multiply it by PreveCeutical Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of February, PreveCeutical Medical holds the Semi Deviation of 16.94, coefficient of variation of 1036.64, and Risk Adjusted Performance of 0.0796. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PreveCeutical Medical, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down nineteen technical drivers for PreveCeutical Medical, which can be compared to its competitors. Please check PreveCeutical Medical variance, as well as the relationship between the maximum drawdown and semi variance to decide if PreveCeutical Medical is priced some-what accurately, providing market reflects its current price of 0.0173 per share. As PreveCeutical Medical appears to be a penny stock we also advise to check out its total risk alpha numbers.PreveCeutical Medical Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as PreveCeutical Medical price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
PreveCeutical Medical Predictive Daily Indicators
PreveCeutical Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PreveCeutical Medical otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PreveCeutical Medical Forecast Models
PreveCeutical Medical's time-series forecasting models are one of many PreveCeutical Medical's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PreveCeutical Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.PreveCeutical Medical Debt to Cash Allocation
Many companies such as PreveCeutical Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity.PreveCeutical Medical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PreveCeutical Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PreveCeutical Medical, which in turn will lower the firm's financial flexibility.About PreveCeutical OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how PreveCeutical Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PreveCeutical shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as PreveCeutical Medical. By using and applying PreveCeutical OTC Stock analysis, traders can create a robust methodology for identifying PreveCeutical entry and exit points for their positions.
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding PreveCeutical Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Complementary Tools for PreveCeutical OTC Stock analysis
When running PreveCeutical Medical's price analysis, check to measure PreveCeutical Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PreveCeutical Medical is operating at the current time. Most of PreveCeutical Medical's value examination focuses on studying past and present price action to predict the probability of PreveCeutical Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PreveCeutical Medical's price. Additionally, you may evaluate how the addition of PreveCeutical Medical to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |